reinnervate Limited, a Durham, UK-based company developing biotechnologies aimed at facilitating research into cell growth and function in vitro, has raised £1.6m in a new funding led by North Star Equity Investors.Established in July 2002, the company is a spin-out from research conducted at Durham University.
It is currently based in a facility within NETPark Incubator.
reinnervate’s technologies, which are particularly relevant in the management of growth and function of cultured cells, have immediate applications for research and development in the academic, healthcare, biotechnology and pharmaceutical sectors.
FinSMEs
31/05/2010